Non-alcoholic fatty liver disease in children: A new complication of obesity;'Non-alcoholic fatty liver disease' bij kinderen: Een nieuwe complicatie van obesitas

Nederlands Tijdschrift voor Geneeskunde

Volumn 152, Issue 45, 2008, Pages 2443-2447

  Bocca, G ^a   Stolk, R P ^a   Scheenstra, R ^a   Sauer, P J J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; INSULIN;

CHRONIC LIVER DISEASE; DIET RESTRICTION; DISEASE ASSOCIATION; FATTY LIVER; HEPATITIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; LIFESTYLE MODIFICATION; LIVER CIRRHOSIS; LIVER FAILURE; LIVER INJURY; METABOLIC SYNDROME X; NETHERLANDS; NON ALCOHOLIC FATTY ACID LIVER DISEASE; OBESITY; PATIENT IDENTIFICATION; PHYSICAL ACTIVITY; PREVALENCE; PRIMARY PREVENTION; REVIEW; RISK ASSESSMENT;

ADOLESCENT; CHILD; EXERCISE; FATTY LIVER; FEMALE; HUMANS; LIFE STYLE; MALE; OBESITY; PREVALENCE; RISK REDUCTION BEHAVIOR; WEIGHT LOSS;

EID: 56249102113     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Ebbeling CB, Pawlak DB, Ludwig DS. Childhood obesity: public-health crisis, common sense cure. Lancet. 2002;360:473-82.
2. Hurk K van den, Dommelen P van, Buuren S van, Verkerk PH, Hirasing RA. Prevalence of overweight and obesity in the Netherlands in 2003 compared to 1980 and 1997. Arch Dis Child. 2007;92:992-5.
3. Fredriks AM, Buuren S van, Wit JM, Verloove-Vanhorick SP. Body index measurements in 1996-7 compared with 1980. Arch Dis Child. 2000;82:107-12.
4. Rotteveel J, Belksma EJ, Renders CM, Hirasing RA, Delemarre-van de Waal HA. Type 2 diabetes in children in the Netherlands: the need for diagnostic protocols. Eur J Endocrinol. 2007;157:175-80.
5. Roberts EA. Pediatric nonalcoholic fatty liver disease (NAFLD): a 'growing' problem? J Hepatol. 2007;46:1133-42.
6. Thewissen CMI, Tiebosch ATM, Kloppenburg WD, Haagsma EB, Hoogenberg K. Levercirrose bij diabetes mellitus, een niet altijd onderkende complicatie. Ned Tijdschr Geneeskd. 2008;152:2369-74.
7. Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics. 2005;115:e561-5.
8. Chan DF, Li AM, Chu WC, Chan MH, Wong EM, Liu EK, et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord. 2004;28:1257-63.
9. Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr. 2000;136:727-33.
10. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118:1388-93.
11. Schwimmer JB, Behling C, Newbury R, Deutsch R, Nievergelt C, Schork NJ, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005;42:641-9.
12. Nobili V, Marcellini M, Devito R, Ciampalini P, Piemonte F, Comparcola D, et al. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology. 2006;44:458-65.
13. Fishbein M, Cox S. Non-alcoholic fatty liver disease in a toddler. Clin Pediatr (Phila). 2004;43:483-5.
14. Moran JR, Ghishan FK, Halter SA, Greene HL. Steatohepatitis in obese children: a cause of chronic liver dysfunction. Am J Gastroenterol. 1983;78:374-7.
15. Molleston JP, White F, Teckman J, Fitzgerald JF. Obese children with steatohepatitis can develop cirrhosis in childhood. Am J Gastroenterol. 2002;97:2460-2.
16. Suzuki D, Hashimoto E, Kaneda K, Tokushige K, Shiratori K. Liver failure caused by non-alcoholic steatohepatitis in an obese young male. J Gastroenterol Hepatol. 2005;20:327-9.
17. Schwimmer JB. Definitive diagnosis and assessment of risk for non-alcoholic fatty liver disease in children and adolescents. Semin Liver Dis. 2007;27:312-8.
18. Day CP. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol. 2002;16:663-78.
19. D'Adamo E, Impicciatore M, Capanna R, Loredana Marcovecchio M, Masuccio FG, Chiarelli F, et al. Liver steatosis in obese prepubertal children: a possible role of insulin resistance. Obesity (Silver Spring). 2008;16:677-83.
20. Fishbein MH, Mogren C, Gleason T, Stevens WR. Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2006;42:83-8.
21. Piano A de, Prado WL, Caranti DA, Siqueira KO, Stella SG, Lofrano M, et al. Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2007;44:446-52.
22. Letteron P, Fromenty B, Terris B, Degott C, Pessayre D. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol. 1996;24:200-8.
23. Day CP. From fat to inflammation. Gastroenterology. 2006;130:207-10.
24. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest. 1995;95:2111-9.
25. Crespo J, Cayón A, Fernández-Gil P, Hernández-Guerra M, Mayorga M, Domínguez-Díez A, et al. Gene expression of tumour necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology. 2001;34:1158-63.
26. Manco M, Marcellini M, Giannone G, Nobili V. Correlation of serum TNF-levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease. Am J Clin Pathol. 2007;127:954-60.
27. Leclercq IA, Farrell GC, Schriemer R, Robertson GR. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol. 2002;37:206-13.
28. Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X, et al. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab. 2006;91:4287-94.
29. Guzzaloni G, Grugni G, Minocci A, Mora D, Morabito F. Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes Relat Metab Disord. 2000;24:772-6.
30. Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr. 2003;143:500-5.
31. Rashid M, Roberts EA. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2000;30:48-53.
32. Liem ET, de Lucia Rolfe E, L'Abée C, Sauer PJJ, Ong KK, Stolk RP. Measuring abdominal adiposity in six- to seven-year-old children. Eur J Clin Nutr. [ter perse].
33. Perseghin G, Bonfanti R, Magni S, Lattuada G, de Cobelli F, Canu T, et al. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. Am J Physiol Endocrinol Metab. 2006;291:6697-703.
34. Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr. 2006;43:413-27.
35. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab. 2005;288:6462-8.
36. Pacifico L, Celestre M, Anania C, Paolantonio P, Chiesa C, Laghi A. MRI and ultrasound for hepatic fat quantification: relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease. Acta Paediatr. 2007;96:542-7.
37. Renders CM, Henneman L, Timmermans DRM, Hirasing RA. Televisiekijken en enkele eetgewoonten bij Amsterdamse 6-14 jarigen; een transversaal onderzoek. Ned Tijdschr Geneeskd. 2004;148:2072-6.
38. Renders CM, Seidell JC, Mechelen W van, Hirasing RA. Overgewicht en obesitas bij kinderen en adolescenten en preventieve maatregelen. Ned Tijdschr Geneeskd. 2004;148:2066-70.
39. Schwimmer JB, Middleton MS, Deutsch R, Lavine JE. A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2005;21:871-9.
40. Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med. 2006;355:2297-307.
41. Hoekstra JBL, Bossuyt PMM, Vries JH de. Twijfels aan de cardiovasculaire veiligheid van rosiglitazon. Ned Tijdschr Geneeskd. 2007;151:1449-50.
42. Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr. 2000;136:734-8.